Xavier Reveles
Fortuna: 2 335 $ al 31/05/2026
Fortuna: 2 335 $ al 31/05/2026
Mr. Xavier T.
Reveles is a Chief Operating Officer at bioAffinity Technologies, Inc., a Director-Cytogenetics Laboratory at University of Texas Health Science Center At San Antonio and a Member at Association for Molecular Pathology.
Mr. Reveles was previously employed as a Laboratory Director by Oncopath Laboratory.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/01/2025 | 1.398 ( 0,03 % ) | 2 335 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Director de Operaciones | 01/01/2017 |
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Corporate Officer/Principal | - |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Oncopath Laboratory | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Health Technology |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopath Laboratory |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.